|
July 2024
Volume 1, Issue 1
| |
|
President's Message
Lisa Pont, FISPE
I am delighted to introduce the inaugural edition of our new newsletter, ISPE Insights. This initiative marks a significant step in our ongoing efforts to enhance communication and engagement within our global community. As the President of ISPE, I am excited to share this platform that will serve as a vital resource for updates, insights, and developments in the field of pharmacoepidemiology. Continue reading.
| |
ISPE 2024 Annual Meeting in Berlin
Andrea Margulis, FISPE
We look forward to welcoming you to the ISPE 2024 Annual Meeting in Berlin! The event will take place from 24 to 28 August at the Estrel Conference Center. The conference center is located on the Berlin Ring—a 37-km long railway line in the approximate shape of a circle, with trains running clockwise and counter-clockwise. I hope you will also enjoy the venue´s waterfront area across the street. Our Local Host Committee has prepared a Visitor´s Guide with information on the city and its neighborhoods, public transport, restaurants, museums, tipping suggestions, and other details. Continue reading.
| |
Embracing the Diversity of Real-Word Data Sources
Romin Pajouheshnia, Rosa Gini, Gillian Hall, Robert Platt, Soko Setoguchi, Shahab Abtahi, Suzanne Landi, Carrie Nielson, Lin Li
With the growing consideration and acceptance of real-world evidence (RWE) by regulatory agencies and health technology assessment bodies in decision-making, the use of real-world data sources (RWDS) has become an ever-increasing interest of the ISPE community. A diverse array of RWDS is being used in pharmacoepidemiologic research. With new approaches to generate and harness different types of health-related data, the diversity will only continue to increase, bringing greater challenges and opportunities for our field. Continue reading.
| |
Policy and Advocacy Updates
Susan dosReis, FISPE
ISPE Funded Manuscripts
There were 14 proposals submitted for the 2023 Call for Funded Manuscript Program. A total of 6 manuscript writing teams were awarded funds to develop their manuscript. In total, ISPE provided $49,900 in support of the Funded Manuscript Program. Congratulations to the writing teams! Continue reading.
| |
Membership Committee Corner
Heather Danysh
Interested in being more engaged in ISPE?
Check out the ISPE Opportunity Pathways to learn about ways to get involved with ISPE!
Members can join the ISPE Mentorship Program any time throughout the year!
Whether you are looking for a mentor or are interested in being a mentor, you can register for the ISPE Mentorship Program to start connecting with other ISPE members and start your mentorship relationship.
Questions on membership benefits, ways to get involved with ISPE, or the ISPE mentorship program? Email the Membership Committee at info@pharmacoepi.org.
| |
|
What’s New at the Drug-Drug Interaction (DDI) SIG?
Cheng (Alice) Chen
Quarterly Journal Clubs
The DDI SIG hosts quarterly journal clubs, offering a platform for sharing and discussing the latest DDI research. In December 2023, Dr. Macarius Donneyong shared his experience using “A data mining approach for the discovery of potentially high- and low-risk high-order drug combinations from real world data.” In March 2024, Dr. Antonios Douros delivered a compelling talk on “Time-Varying Exposure Definitions in Drug-Drug Interactions,” using real-world examples to illustrate the design. In June 2024, Dr. Sungho Bae presented his recent publication on the impact of combining Sodium-Glucose Cotransporter 2 Inhibitors with Overactive Bladder Drugs on urinary tract infection risk, which received high praise. Continue reading.
| |
Celebrating 40 years of ISPE
Eileen Ming, FISPE
Did you know that the first five ISPE (formerly known as ICPE) meetings were held in Minneapolis, Minnesota (United States), and it was at the fifth meeting that the International Society for Pharmacoepidemiology was officially launched by Stanley Edlavitch, David Lilienfeld, and Hugh Tilson?
History matters because it is the laboratory of human experience. Data from our past provides an extensive evidence-base to help inform our present and our future. Continue reading.
| |
|
News from the Student Council
Liz Mansi
We hope you’ve enjoyed the career talks and technical webinars presented so far this year. If you missed any, did you know you can access previous recordings at https://webed.pharmacoepi.org? One way to ensure you don’t miss any announcements or events in the future is to sign up for alerts from the student council (and any other councils, special interest groups (SIGs) or regional interest groups (RIGs) that you are interested in) at the ISPE Exchange, by clicking ‘Join a community’, and then ‘Join’ next to the notifications you want to receive. SIG leaders want you to know that students are very encouraged to join SIGs. Continue reading.
| |
|
The Medications in Pregnancy and Lactation (MiPaL) SIG
Sandra Lopez-Leon
The Medications in Pregnancy and Lactation (MiPaL) SIG invites you to view our May 2024 newsletter. Feel free to share with others outside of ISPE/ the SIG, as you like. If you are interested in these topics, join our SIG: we would love to have you.
| | |
|
ISPE
529 14th St NW Ste 1280
Washington, DC 20045
www.pharmacoepi.org
| |
| | | |
